Berry Consultants Webinar on SARS-COV-2 Vaccine Trials

On Friday, October 2, Berry Consultants hosted its monthly FACTS webinar on SARS-COV-2 vaccine trials and opened it up to the broader public to attend.

Dr. Kert Viele of Berry Consultants presented on the recently released protocols for the SARS-COV-2 vaccine trials (from Pfizer, Moderna, AstraZeneca, and Janssen), focusing on both efficacy and safety questions. This included topics related to number of interims, interim timing, Bayesian vs Frequentist methods, and the information available for different safety questions.  Dr. Viele’s presentation slides can be found here.

The webinar was recorded and is available on Berry Consultants YouTube Channel located here.

More Recent News

February 2024 QUOTES Webinar

Berry Consultants will be hosting a webinar on the optimization of a clinical trial design by estimating its impact on the expected net present value of a drug development program using the software QUOTES (Quantification and Optimization of Trial Expectations Simulator).

Blog: Precision Promise Adaptive Platform Trial update

Blog by: Kert Viele News from the Precision Promise platform trial. https://fibrogen.gcs-web.com/news-releases/news-release-details/fibrogen-announces-completion-pamrevlumab-arm-precision-promise Precision Promise is an adaptive platform trial investigating potential therapies for pancreatic cancer,

January 2024 FACTS Webinar

The Berry Consultants software team will be hosting its January FACTS webinar next Friday, January 19th at 11am EST to present the development plans for adding an ordinal endpoint option to the trial simulator.

Blog: Comments on the draft FDA master protocol guidance

Blog by: Kert Viele The FDA draft master protocol guidance is out https://www.fda.gov/regulatory-information/search-fda-guidance-documents/master-protocols-drug-and-biological-product-development Comments are due by February 22. Here are some preliminary thoughts and